Stocks Touched New Highs: Apple Inc. (NASDAQ:AAPL), Northstar Realty Finance Corp. (NYSE:NRF), AstraZeneca plc (ADR) (NYSE:AZN), Exxon Mobil Corporation (NYSE:XOM)

Once the world’s largest smartphone maker with a market share topping 50 per cent, Nokia dropped outside the top five with about 3 percent share as Apple Inc. (NASDAQ:AAPL)’s iPhone and phones running Google Inc’s Android software gained dominance. Apple Inc. (NASDAQ:AAPL) stock performance was 3.87% in last session and finished the day at $594.09….

Read More
FB Nasdaq FB Facebook

Healthcare Watch List: Arena Pharmaceuticals (NASDAQ:ARNA), Abbott Laboratories (NYSE:ABT), UnitedHealth Group (NYSE:UNH), AstraZeneca (NYSE:AZN)

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) reported that Eisai Inc. has launched a national television advertising campaign for BELVIQ® (lorcaserin HCl), an FDA-approved prescription treatment for chronic weight management. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) stock performance was 0.32% in last session and finished the day at $6.20. Traded volume was 4.92million shares in the last session and the…

Read More

Unusual Volume Buzzers: Cbeyond (NASDAQ:CBEY), Advanced Micro Devices (NYSE:AMD), Sarepta Therapeutics Inc (NASDAQ:SRPT), AstraZeneca (NYSE:AZN)

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty to current shareholders of Cbeyond, Inc. (NASDAQ:CBEY) and other violations of state law by the board of directors of Cbeyond Inc. (NASDAQ:CBEY) relating to the proposed buyout of the Company by Birch Communications, Inc….

Read More
Gilead Sciences GILD NASDAQ:GILD

Trending Stocks: Weibo Corp (ADR) (NASDAQ:WB), AstraZeneca (NYSE:AZN), AutoZone (NYSE:AZO), Google Inc (NASDAQ:GOOG)

The two companies that sold their shares within their marketed range—China’s Leju Holdings Ltd. and Weibo Corp. (ADR) (NASDAQ:WB), both opted the day of their offerings to sell fewer shares than planned. Weibo Corp (ADR) (NASDAQ:WB) stock performance was 19.06% in last session and finished the day at $20.24. According to reports, Pfizer Inc. considered…

Read More